Display options
Cite
Shank Coviello J. Cardiac side effects of targeted therapies. Semin Oncol Nurs. 2014;30(3):175-82doi: 10.1016/j.soncn.2014.05.005.
Shank Coviello, J. (2014). Cardiac side effects of targeted therapies. Seminars in oncology nursing, 30(3), 175-82. https://doi.org/10.1016/j.soncn.2014.05.005
Shank Coviello, Jessica. "Cardiac side effects of targeted therapies." Seminars in oncology nursing vol. 30,3 (2014): 175-82. doi: https://doi.org/10.1016/j.soncn.2014.05.005
Shank Coviello J. Cardiac side effects of targeted therapies. Semin Oncol Nurs. 2014 Aug;30(3):175-82. doi: 10.1016/j.soncn.2014.05.005. PMID: 25085029.
Copy Download .nbib Format: NLM
Share it on

Semin Oncol Nurs. 2014 Aug;30(3):175-82. doi: 10.1016/j.soncn.2014.05.005.

Cardiac side effects of targeted therapies.

Seminars in oncology nursing

Jessica Shank Coviello

PMID: 25085029 DOI: 10.1016/j.soncn.2014.05.005

Abstract

OBJECTIVES: To review common cardiac side effects, their clinical presentation, and recommendations for assessment and management of patients receiving molecularly targeted cancer therapies.

DATA SOURCES: Peer-reviewed literature.

CONCLUSION: Although there is no established guideline for pretreatment cardiac evaluation and monitoring of patients receiving molecularly targeted agents, data currently supports the need for early risk identification and prevention/reduction strategies.

IMPLICATIONS FOR NURSING PRACTICE: As nurses, we have a unique opportunity to help improve and maintain the quality of life of cancer survivors. Cardiovascular assessment and prevention/reduction strategies are essential to reduce risk of cardiovascular disease, promote optimal quality of life, and improve survival outcomes in patients receiving molecularly targeted cancer treatment.

Copyright © 2014 Elsevier Inc. All rights reserved.

Keywords: Cardiotoxicity; cardiovascular assessment; targeted therapy

MeSH terms

Publication Types